Bridging the gap between innovation and capital
Northpond Ventures
Focus on life sciences, biotechnology, and diagnostics
Program
Northpond Ventures is a global science-driven venture capital firm dedicated to advancing breakthrough science and technology for the benefit of humanity. Headquartered in Bethesda, MD, with offices in Cambridge, MA, and San Francisco, CA, the firm manages a portfolio of 60+ companies with over $1B in committed capital.
Event
LaunchBio, Browne Consulting, and Silicon Valley Bank, a division of First Citizens Bank, with support by Fondation Ipsen, are pleased to announce their next Investor Connect virtual event with Northpond Ventures.
Northpond is a leading biotech investor, backing transformative companies from seed through Series B while providing strategic guidance to help scale and commercialize innovations. Its team combines scientific, clinical, and financial expertise to support founders in science and healthcare.
Beyond direct investments, Northpond operates Northpond Labs, a translational research platform that partners with Harvard’s Wyss Institute, MIT’s School of Engineering, and Stanford Medicine to fund and advance proof-of-concept programs, turning academic discoveries into commercial ventures.
Applications will be selected based on meeting the following criteria:
Geography
Primarily in the US and Europe
Company type
Focus on life sciences, biotechnology, diagnostics, digital health, and enabling technologies.
Modalities of Interest
- Gene therapies
- Cell therapies (including non-viral and engineered approaches)
- RNA-based therapeutics
- Protein and antibody engineering
- Synthetic biology
- NGS and molecular diagnostics
- Enabling life science tools and platforms
Therapeutic areas include, but are not limited to:
- Oncology
- Neurology
- Immunology
- Infectious diseases
- Rare diseases
- Other high-impact areas where breakthrough science can significantly advance healthcare
Stage
Companies seeking Seed, Series A, and Series B (with flexibility for later stage opportunities).
Qualifying start-ups can apply here today.
Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Browne Consulting and Silicon Valley Bank, a division of First Citizens Bank.